6.48
+0.29
Volume
1,790,864
Prev. Close
6.19
Day's Range
6.02 - 6.48
Open
6.10
52-Week Range
3.10 - 7.73
User Opinion:
Fri, May 03, 2013
Company Update - Fri 3 May, 2013
-
Korelin Economics Re...
Wed, Apr 17, 2013
Al's Insights - Wed 17 Apr, 2013
-
Korelin Economics Re...
Tue, Mar 26, 2013
Company Update - Tue 26 Mar, 2013
-
Korelin Economics Re...
Mon, Mar 25, 2013
Company Update - Mon 25 Mar, 2013
-
Korelin Economics Re...
Sat, Mar 09, 2013
Weekend Show - Sat 9 Mar, 2013
-
Korelin Economics Re...
Thu, Jan 24, 2013
Orex Minerals Proposed Share Split
-
Korelin Economics Re...
Mon, Jan 14, 2013
Orex Minerals Drill Results Explained
-
Korelin Economics Re...
Tue, Jan 08, 2013
Company Update - Tue 8 Jan, 2013
-
Korelin Economics Re...
Mon, Nov 26, 2012
Ben Whiting on Orex Drill Program Striking Visible Gold
-
Korelin Economics Re...
Fri, Nov 23, 2012
Gary Cope, One of the Largest Primary Undeveloped Silver Deposits
-
Korelin Economics Re...
More Podcasts
Today
Commit To Purchase Orexigen Therapeutics At $3, Earn 23.3%
-
Market News Video
Commit To Purchase Orexigen Therapeutics At $3, Earn 23.3%
-
Dividend Channel
Mon, May 20, 2013
Orexigen Therapeutics Earnings Review: 12 Days after Announcement Shares Up 0.7% (OREX)
-
Comtex SmarTrend® Ne...
Sat, May 11, 2013
Why Does Arena's Obesity Drug Have Abuse Potential?
-
Forbes Real Time
Wed, May 08, 2013
Will The Prescription Diet Pill Market Finally Bulk Up?
-
Forbes Real Time
Mon, May 06, 2013
MDT, HLF, OREX, and NVS Early Briefing and Review
-
ACCESSWIRE
Fri, May 03, 2013
VIVUS, Inc. (VVUS) Ticks Higher as Arena (ARNA) Pulls BELVIQ MAA in Europe
-
StreetInsider
Arena Withdraws Application for Weight-Loss Drug Approval in Europe
-
DailyFinance.com
Fri, Apr 26, 2013
Equities Review and Reports For (NYSE: RDN) (NASDAQ: OREX)
-
ACCESSWIRE
Thu, Apr 25, 2013
Orexigen Therapeutics Has Returned 17.5% Since SmarTrend Recommendation (OREX)
-
Comtex SmarTrend® Ne...
More News
Today
NASDAQ Gainers Watch List: VIVUS Inc. (NASDAQ:VVUS), Theravance Inc. (NASDAQ:THRX), and Orexigen Therapeutics, Inc. (NASDAQ:OREX) Added to Equity Profile Report's NASDAQ Gainers Watch List.
-
SBWire - Latest Pres...
Wed, May 15, 2013
NASDAQ Decliners Watch List: Rockwell Medical, Inc. (NASDAQ:RMTI), VIVUS Inc. (NASDAQ:VVUS), and Orexigen Therapeutics, Inc. (NASDAQ:OREX) Added to Growing Stock Report's NASDAQ Decliners Watch List.
-
SBWire - Latest Pres...
Tue, May 14, 2013
Orexigen Therapeutics, Inc. (NASDAQ:OREX) Investor Alert: Investigation over Potential Wrongdoing
-
SBWire - Latest Pres...
Tue, Apr 23, 2013
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Orexigen Therapeutics, Inc. (NASDAQ:OREX), and Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) Added to Growing Stock Report's NASDAQ Gainers Watch List.
-
SBWire - Latest Pres...
Thu, Apr 18, 2013
Stocks in News: ABIOMED, Dynavax Technologies, Orexigen Therapeutics, BioCryst Pharmaceuticals
-
SBWire - Latest Pres...
Wed, Apr 17, 2013
ABIOMED, Inc. (NASDAQ:ABMD), Orexigen Therapeutics, Inc. (NASDAQ:OREX), and Sinovac Biotech Ltd. (NASDAQ:SVA) Added to Growing Stock Report's NASDAQ Gainers Watch List.
-
SBWire - Latest Pres...
Thu, Apr 11, 2013
Stock Losers: Anheuser-Busch InBev NV, Illumina, Orexigen Therapeutics, Arch Coal Inc
-
SBWire - Latest Pres...
Thu, Apr 04, 2013
NASDAQ Decliners Watch List: Orexigen Therapeutics, Inc. (NASDAQ:OREX), Synageva BioPharma Corp. (NASDAQ:GEVA), and Hyperion Therapeutics, Inc. (NASDAQ:HPTX) Added to Growing Stock Report's NASDAQ Dec
-
SBWire - Latest Pres...
Mon, Apr 01, 2013
Stocks to Track: Foster Wheeler AG, LKQ Corporation, Orexigen Therapeutics, Crocs
-
SBWire - Latest Pres...
Notable Gainers: MGIC Investment Corp.(NYSE:MTG) , ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Orexigen Therapeutics, Inc.(NASDAQ:OREX)
-
SBWire - Latest Pres...
More Blogs
ADVERTISEMENT
3
2
7
5
4
10
8
6
16
8
11
13
17
1
14
12
15
26
18
20
Attention Podcasters!
If you are a business podcaster looking for more listeners, you've come to the right place. Update your RSS feeds using our specs and effectively syndicate your podcasts to AOL, ABC, CBS, Fox, MNG, Hearst and other leading media outlets. For more information, please email us at
info@streetiq.com .
Are you creating a special series or covering an event? Submit links to your podcasts and photos along with captions and shownotes to
buzz@streetiq.com .